British Patient Capital announces £25m commitment to SV Health Investors’ Dementia Discovery Fund 2
Ria Health Raises Growth Capital to Accelerate Access to Patient-Driven AUD Treatment
2024 SV Therapeutics Impact & ESG Report
Read More
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise
Spineology® Announces $25 Million Equity Financing – Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant portfolio –
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
Read More
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
SV News
- 30 June 2022Portfolio NewsRia Health Secures $18 Million Series A to Scale Online Alcohol Use Disorder Treatment
9 June 2022Portfolio NewsMemorial Hermann Health System Joins Existing Investors in Leiters, a 503B Outsourced Pharmaceutical Compounding Industry Leader
8 June 2022Portfolio NewsSV Health Investors announces acquisition of Nordic Consulting Partners by Accrete Health Partners, a strategic holding company of Bon Secours Mercy Health- 8 February 2022Portfolio NewsNordic named Best in KLAS for Overall IT Services, recognized for its industry-leading Advisory Services
- 8 February 2022Portfolio NewsLeiters Announces Facility Acquisition to Increase Capacity, Accommodate Growth and Expand Portfolio
8 December 2021Portfolio NewsCentauri Health Solutions Adds Clinical Data Exchange Capabilities with Acquisition of Secure Exchange Solutions
9 November 2021Portfolio NewsWelsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters
29 October 2021Portfolio NewsBioventus Completes the Acquisition of Misonix
19 August 2021Portfolio NewsSV Health Investors Announces Three Realizations in its Growth Equity Portfolio- 3 August 2021SV NewsPaul LaViolette describes SV's investment focus
29 July 2021Portfolio NewsWellSky® to Acquire Healthify to Enhance Social Services Care Coordination Across the Continuum- 29 July 2021Portfolio NewsBioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
